4BB 4basebio Plc

 
TIDM4BB 
 
9 June 2022 
 
                                 4basebio PLC 
                         ("4basebio" or the "Company") 
                      Annual General Meeting 2022 ("AGM") 
 
4basebio Plc (AIM: 4BB), the specialist life sciences group focused on 
exploiting intellectual property in the field of cell and gene therapies and 
DNA and mRNA vaccines, announces that all of the resolutions proposed at its 
Annual General Meeting held earlier today were duly passed. 
 
The Company also wishes to again draw attention to the investor meeting being 
held on 13 June 2022, through the Investor Meet Company platform at 10.00am. 
Investors can sign up to Investor Meet Company for free and register interest 
here: 
 
https://www.investormeetcompany.com/register-investor 
 
For further enquiries, please contact: 
 
4basebio PLC                                                     +44 (0)12 2396 
7943 
 
Heikki Lanckriet 
 
Nominated Adviser                                                 +44 (0)20 
7213 0880 
 
Cairn Financial Advisers LLP 
 
Jo Tuner / Sandy Jamieson 
 
Broker                                                                +44 (0)20 
7220 0500 
 
finnCap Ltd 
 
Geoff Nash/Richard Chambers/Charlotte Sutcliffe 
 
Notes to Editors 
 
About 4basebio 
 
4basebio (AIM: 4BB) is a specialist life sciences group focused on therapeutic 
DNA for cell and gene therapies and DNA vaccines and providing solutions for 
effective and safe delivery of these DNA based products to patients. It is the 
intention of the Company to become a market leader in the manufacture and 
supply of high purity, synthetic DNA for research, therapeutic and 
pharmacological use and develop non-viral vectors for the efficient delivery of 
payloads. The immediate objectives of 4basebio are to continue the validation 
of its DNA products and HermesT technology and commence revenue generation 
during 2022. 4basebio also continues to advance its collaborations to 
facilitate the functional validation of its DNA based products and cell and 
gene delivery solutions. 
 
 
 
END 
 
 

(END) Dow Jones Newswires

June 09, 2022 06:39 ET (10:39 GMT)

4basebio (LSE:4BB)
Historical Stock Chart
From Apr 2024 to May 2024

4basebio (LSE:4BB)
Historical Stock Chart
From May 2023 to May 2024